Telomere length in myelodysplastic syndromes

References

• Baird DM, Kipling D. The extent and significance of telomere loss with age. Ann NY Acad Sci 2004;1019:265–268.
   PubMed Web of Science ®Google Scholar
• Londono-Vallejo JA. Telomere length heterogeneity and chromosome instability. Cancer Lett 2004;212:135–144.
   PubMed Web of Science ®Google Scholar
• Boultwood J, Fidler C, Kusec R, et al. Telomere length in myelodysplastic syndromes. Am J Hematol 1997;56:266–271.
   PubMed Web of Science ®Google Scholar
• Brummendorf TH, Holyoake TL, Rufer N, et al. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 2000;95:1883–1890.
   PubMed Web of Science ®Google Scholar
• Ohyashiki JH, Iwama H, Yahata N, et al. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes. Clin Cancer Res 1999;5:1155–1160.
   PubMed Web of Science ®Google Scholar
• Rigolin GM, Porta MD, Bugli AM, et al. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings. Eur J Haematol 2004;73:351–358.
   PubMed Web of Science ®Google Scholar
• Sashida G, Ohyashiki JH, Nakajima A, et al. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases. Clin Cancer Res 2003;9:1489–1496.
   PubMed Web of Science ®Google Scholar
• Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211–1218.
   PubMed Web of Science ®Google Scholar
• Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007;67:5538–5544.
   PubMed Web of Science ®Google Scholar
• Mirabello L, Garcia-Closas M, Cawthon R, et al. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 2010;21:77–82.
   PubMed Web of Science ®Google Scholar
• McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007;16: 815–819.
   PubMed Web of Science ®Google Scholar
• Jang JS, Choi YY, Lee WK, et al. Telomere length and the risk of lung cancer. Cancer Sci 2008;99:1385–1389.
   PubMed Web of Science ®Google Scholar
• Calado RT, Regal JA, Hills M, et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci USA 2009;106:1187–1192.
   PubMed Web of Science ®Google Scholar
• Calado RT, Young NS. Telomere diseases. N Engl J Med 2009;361:2353–2365.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 2005;352:1413–1424.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835–3849.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292–2302.
   PubMed Web of Science ®Google Scholar
• Sanz GF, Sanz MA, Greenberg PL. Prognostic factors and scoring systems in myelodysplastic syndromes. Haematologica 1998;83:358–368.
   PubMed Web of Science ®Google Scholar
• Tarone RE, Alavanja MC, Zahm SH, et al. The Agricultural Health Study: factors affecting completion and return of self-administered questionnaires in a large prospective cohort study of pesticide applicators. Am J Ind Med 1997;31:233–242.
   PubMed Web of Science ®Google Scholar
• Rogers NL, Cole SA, Lan HC, Crossa A, Demerath EW. New saliva DNA collection method compared to buccal cell collection techniques for epidemiological studies. Am J Hum Biol 2007;19:319–326.
   PubMed Web of Science ®Google Scholar
• Rylander-Rudqvist T, Hakansson N, Tybring G, Wolk A. Quality and quantity of saliva DNA obtained from the self-administrated oragene method–a pilot study on the cohort of Swedish men. Cancer Epidemiol Biomarkers Prev 2006;15: 1742–1745.
   PubMed Web of Science ®Google Scholar
• Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003;361:393–395.
   PubMed Web of Science ®Google Scholar
• Schmid I, Dagarag MD, Hausner MA, et al. Simultaneous flow cytometric analysis of two cell surface markers, telomere length, and DNA content. Cytometry 2002;49:96–105.
   PubMedGoogle Scholar
• Kapoor V, Hakim FT, Rehman N, Gress RE, Telford WG. Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry. J Immunol Methods 2009;344:6–14.
   PubMed Web of Science ®Google Scholar
• Vindelov LL, Christensen IJ, Nissen NI. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 1983;3:328–331.
   PubMedGoogle Scholar
• Wang L, Soria JC, Chang YS, Lee HY, Wei Q, Mao L. Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer. Oncogene 2003; 22:7123–7129.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Sun CL, Francisco L, et al. Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. J Clin Oncol 2009;27: 791–798.
   PubMed Web of Science ®Google Scholar
• Marcondes AM, Bair S, Rabinovitch PS, Gooley T, Deeg HJ, Risques R. No telomere shortening in marrow stroma from patients with MDS. Ann Hematol 2009;88:623–628.
   PubMed Web of Science ®Google Scholar
• Calado RT, Young NS. Telomere maintenance and human bone marrow failure. Blood 2008;111:4446–4455.
   PubMed Web of Science ®Google Scholar
• Calado RT. Telomeres and marrow failure. Hematology Am Soc Hematol Educ Program 2009;338–343.
   PubMedGoogle Scholar
• Yamaguchi H. Mutations of telomerase complex genes linked to bone marrow failures. J Nippon Med Sch 2007;74:202–209.
   PubMedGoogle Scholar
• Ohyashiki K, Shay JW, Ohyashiki JH. Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome. Haematologica 2005;90:691.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Baerlocher GM, Lansdorp PM, et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 2003;102:916–918.
   PubMed Web of Science ®Google Scholar
• Kirwan M, Vulliamy T, Marrone A, et al. Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia. Hum Mutat 2009;30: 1567–1573.
   PubMed Web of Science ®Google Scholar
• Albin M, Bjork J, Welinder H, et al. Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures. Scand J Work Environ Health 2003;29:378–387.
   PubMed Web of Science ®Google Scholar
• Ciccone G, Mirabelli D, Levis A, et al. Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study. Cancer Genet Cytogenet 1993;68:135–139.
   PubMed Web of Science ®Google Scholar
• Rigolin GM, Cuneo A, Roberti MG, et al. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. Br J Haematol 1998;103:189–197.
   PubMed Web of Science ®Google Scholar
• West RR, Stafford DA, White AD, Bowen DT, Padua RA. Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure. Blood 2000;95: 2093–2097.
   PubMed Web of Science ®Google Scholar